Ruxolitinib is a type of oral targeted therapy called a kinase inhibitor and is mainly used to treat diseases such as graft-versus-host disease, erythroblastosis, and medium-and high-risk myelofibrosis, while Ruxolitinib cream is a topical dermatological agent that is applied directly on the skin to treat a eczema, vitiligo, atopic dermatitis, and baldness. Though Ruxolitinib and […]
